BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/14/2025 5:49:40 AM | Browse: 268 | Download: 632
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 108484
Country China
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Retrospective Study
Article Title Postoperative adjuvant PD-1 immunotherapy survival and body-mass-index dynamics in esophageal cancer: A real-world retrospective study
Manuscript Source Unsolicited Manuscript
All Author List Liu-Yu Li, Mei-Qing Zhang, Wen-Min Ying, Wen-Zhen Zhang, Wei-Jing Jiang, Ting-Jie Xiong, Feng-Mei Wang and Zhi-Chao Fu
ORCID
Author(s) ORCID Number
Liu-Yu Li http://orcid.org/0009-0001-5996-1426
Zhi-Chao Fu http://orcid.org/0000-0001-8096-3496
Funding Agency and Grant Number
Funding Agency Grant Number
Wu Jieping Medical Foundation 320.6750.2024-16-28
Corresponding Author Zhi-Chao Fu, Department of Radiotherapy, Fuzong Clinical Medical College of Fujian Medical University, No. 156 West Second Ring Road North, Fuzhou 350112, Fujian Province, China. fauster1112@126.com
Key Words Postoperative treatment; Esophageal cancer; Adjuvant immunotherapy; Body mass index difference; Exploratory Data Analysis
Core Tip This single-center, retrospective real-world study investigated the efficacy of adjuvant PD-1 immunotherapy following radical surgery for esophageal cancer and identifying related prognostic factors. A literature review published in the past 5 years on PubMed revealed no existing studies on this topic, making this research innovative. Additionally, the study found that the difference in body mass index (BMI) between the preoperative period and initiation of the first immunotherapy session serves as an independent prognostic factor. Specifically, a BMI difference < 3.86 was associated with better prognosis, providing valuable insights for guiding personalized follow-up treatment.
Publish Date 2025-08-14 05:49
Citation

Li LY, Zhang MQ, Ying WM, Zhang WZ, Jiang WJ, Xiong TJ, Wang FM, Fu ZC. Postoperative adjuvant PD-1 immunotherapy survival and body-mass-index dynamics in esophageal cancer: A real-world retrospective study. World J Gastrointest Oncol 2025; 17(8): 108484

URL https://www.wjgnet.com/1948-5204/full/v17/i8/108484.htm
DOI https://dx.doi.org/10.4251/wjgo.v17.i8.108484
Full Article (PDF) WJGO-17-108484-with-cover.pdf